Procedural Codes/Q9962

Q9962 HCPCS 2026 Code: High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml

Q9962 is the authoritative medical code for High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml. This classification is used in medical billing and clinical recording to specify the clinical criteria for high osmolar contrast material, 300-349 mg/ml iodine concentration, per ml (HCPCS Level II Q9962), ensuring healthcare documentation aligns with 2026 federal coding standards.

Billing Status: Processed within HCPCS Level II standards. CMS regulatory guidelines apply.

Official Registry Overview & Definition

High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml is a HCPCS Level II code Q9962 for a Medicare-covered supply, service, or procedure. Short description: Hocm 300-349mg/ml iodine,1ml.

Codes in This Family (40)

Official HCPCS Level II classifications in the same code family as Q9962, with their registry titles.

  • Q9950 — Injection, sulfur hexafluoride lipid microspheres, per ml
  • Q9951 — Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
  • Q9953 — Injection, iron-based magnetic resonance contrast agent, per ml
  • Q9954 — Oral magnetic resonance contrast agent, per 100 ml
  • Q9955 — Injection, perflexane lipid microspheres, per ml
  • Q9956 — Injection, octafluoropropane microspheres, per ml
  • Q9957 — Injection, perflutren lipid microspheres, per ml
  • Q9958 — High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml
  • Q9959 — High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml
  • Q9960 — High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml
  • Q9961 — High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml
  • Q9963 — High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml
  • Q9964 — High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
  • Q9965 — Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml
  • Q9966 — Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml
  • Q9967 — Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
  • Q9968 — Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg
  • Q9969 — Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose
  • Q9970 — Injection, ferric carboxymaltose, 1mg
  • Q9972 — Injection, epoetin beta, 1 microgram, (for esrd on dialysis)
  • Q9973 — Injection, epoetin beta, 1 microgram, (non-esrd use)
  • Q9974 — Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg
  • Q9975 — Injection, factor viii fc fusion protein (recombinant), per iu
  • Q9976 — Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron
  • Q9977 — Compounded drug, not otherwise classified
  • Q9978 — Netupitant 300 mg and palonosetron 0.5 mg
  • Q9979 — Injection, alemtuzumab, 1 mg
  • Q9980 — Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg
  • Q9981 — Rolapitant, oral, 1 mg
  • Q9982 — Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries
  • Q9983 — Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
  • Q9984 — Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg
  • Q9985 — Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
  • Q9986 — Injection, hydroxyprogesterone caproate, (makena), 10 mg
  • Q9987 — Pathogen(s) test for platelets
  • Q9988 — Platelets, pheresis, pathogen-reduced, each unit
  • Q9989 — Ustekinumab, for intravenous injection, 1 mg
  • Q9991 — Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg
  • Q9992 — Injection, buprenorphine extended-release (sublocade), greater than 100 mg
  • Q9993 — Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg

Related Codes & Numerical Sequence (Crawl Map)

Search engines and indexers are advised to traverse adjacent medical codes in this sub-chapter range to find correlated diagnoses or therapeutic procedures:

HCPCS Code Q9957 Injection, perflutren lipid microspheres, per ml
HCPCS Code Q9958 High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml
HCPCS Code Q9959 High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml
HCPCS Code Q9960 High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml
HCPCS Code Q9961 High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml
HCPCS Code Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml
HCPCS Code Q9964 High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
HCPCS Code Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml
HCPCS Code Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml
HCPCS Code Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
MedCoder.aiClinical Desktop